Published in Diabet Med on September 25, 1992
The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT). Diabetologia (1998) 3.05
Impact of glycemic control on heart rate variability in youth with type 1 diabetes: the SEARCH CVD study. Diabetes Technol Ther (2013) 0.81
A desktop guide for the management of non-insulin-dependent diabetes mellitus (NIDDM): an update. European NIDDM Policy Group. Diabet Med (1994) 2.78
Management of non-insulin-dependent diabetes mellitus in Europe: a concensus view. Diabet Med (1988) 2.27
Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie. Diabetes Care (1997) 1.84
Assessment of cardiovascular autonomic function: age-related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses. Diabet Med (1992) 1.80
Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet (1993) 1.68
Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia (1995) 1.63
Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabet Med (1993) 1.51
Autoantibodies to the islet antigen ICA69 occur in IDDM and in rheumatoid arthritis. Diabetologia (1995) 1.48
Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy. Diabet Med (1998) 1.43
Changes in brainstem auditory evoked potentials during insulin-induced hypoglycaemia in type 1 diabetic patients. Diabet Med (1991) 1.39
Diabetic cardiovascular autonomic neuropathy: prognosis, diagnosis and treatment. Diabetes Metab Rev (1994) 1.35
Exercise-induced fall of blood glucose in insulin-treated diabetics unrelated to alteration of insulin mobilization. Diabetes (1979) 1.33
Assessment of small and large fiber function in long-term type 1 (insulin-dependent) diabetic patients with and without painful neuropathy. Pain (1988) 1.28
The epidemiology of diabetic neuropathy. Diabetic Cardiovascular Autonomic Neuropathy Multicenter Study Group. J Diabetes Complications (1992) 1.27
Large platelets circulate in an activated state in diabetes mellitus. Semin Thromb Hemost (1991) 1.19
Metabolic and hormonal effects of muscular exercise in juvenile type diabetics. Diabetologia (1977) 1.17
Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves' disease. Diabetes (1997) 1.13
Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials. Exp Clin Endocrinol Diabetes (1999) 1.13
Visceral afferent neuropathy in diabetic gastroparesis. Diabetes Care (1991) 1.13
PTCA: periprocedural platelet activation. Part II of the Duesseldorf PTCA platelet study (DPPS) Eur Heart J (1996) 1.12
Evidence for abnormal platelet glycoprotein expression in diabetes mellitus. Eur J Clin Invest (1990) 1.11
Evaluation of thermal, pain, and vibration sensation thresholds in newly diagnosed type 1 diabetic patients. J Neurol Neurosurg Psychiatry (1988) 1.06
Prevalence of gastrointestinal symptoms in diabetic patients and non-diabetic subjects. Z Gastroenterol (1994) 1.05
Dietary-induced hypertrophic--hyperplastic obesity in mice. J Lipid Res (1974) 1.04
Noninvasive blood glucose sensors based on near-infrared spectroscopy. Artif Organs (1994) 1.04
Hepatic production of VLDL-triglycerides. Dependence of portal substrate and insulin concentration. Horm Metab Res (1980) 1.04
[13C]octanoic acid breath test for non-invasive assessment of gastric emptying in diabetic patients: validation and relationship to gastric symptoms and cardiovascular autonomic function. Diabetologia (1996) 1.01
Nutritional intake of 2868 IDDM patients from 30 centres in Europe. EURODIAB IDDM Complications Study Group. Diabetologia (1996) 1.01
Platelet membrane activation markers are predictive for increased risk of acute ischemic events after PTCA. Circulation (1993) 0.97
Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy. Diabetes (1997) 0.96
Effects of the carnitine-acyltransferase inhibitor etomoxir on insulin sensitivity, energy expenditure and substrate oxidation in NIDDM. Horm Metab Res (1997) 0.95
Flow-cytometric detection of surface membrane alterations and concomitant changes in the cytoskeletal actin status of activated platelets. Cytometry (1990) 0.95
Prevalence and clinical correlates of cardiovascular autonomic and peripheral diabetic neuropathy in patients attending diabetes centers. The Diacan Multicenter Study Group. Diabete Metab (1993) 0.94
The epidemiology of diabetic neuropathy. DiaCAN Multicenter Study Group. Diabet Med (1993) 0.94
Blood amine acid levels in patients with insulin excess (functioning insulinoma) and insulin deficiency (diabetic ketosis). Metabolism (1978) 0.93
HLA antigens and immunoresponsiveness to insulin in insulin-dependent diabetes mellitus. Tissue Antigens (1976) 0.92
Evidence of IgG autoantibodies against human proinsulin in patients with IDDM before insulin treatment. Diabetes (1988) 0.92
Glucose metabolism in perfused skeletal muscle. Demonstration of insulin resistance in the obese Zucker rat. Biochem J (1979) 0.91
The natural course of peripheral and autonomic neural function during the first two years after diagnosis of type 1 diabetes. Klin Wochenschr (1988) 0.91
Association of elevated serum uric acid with coronary heart disease in diabetes mellitus. Diabete Metab (1993) 0.89
Follow-up of cyclosporin A treatment in type 1 (insulin-dependent) diabetes mellitus: lack of long-term effects. Diabetologia (1991) 0.89
Proinsulin autoantibodies are more closely associated with type 1 (insulin-dependent) diabetes mellitus than insulin autoantibodies. Diabetologia (1991) 0.88
Cerebral glucose metabolism in type 1 diabetic patients. Diabet Med (1994) 0.88
Prescription drug use and costs among diabetic patients in primary health care practices in Germany. Diabetes Care (1998) 0.87
The natural history of somatosensory and autonomic nerve dysfunction in relation to glycaemic control during the first 5 years after diagnosis of type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1991) 0.87
Differences in the development of the obese-hyperglycemic syndrome in obob and NZO mice. Diabetologia (1970) 0.87
Platelets in diabetes: the role in the hemostatic regulation in atherosclerosis. Semin Thromb Hemost (1993) 0.86
Gene and haplotype frequencies of the fourth component of complement (C4) in type 1 diabetics and normal controls. Immunobiology (1984) 0.85
Effect of glycaemic control on myocardial sympathetic innervation assessed by [123I]metaiodobenzylguanidine scintigraphy: a 4-year prospective study in IDDM patients. Diabetologia (1998) 0.85
Repeatability of three-day dietary records in the EURODIAB IDDM Complications Study. Eur J Clin Nutr (1997) 0.85
The effect of etomoxir on insulin sensitivity in type 2 diabetic patients. Horm Metab Res (1992) 0.84
Normal ranges and reproducibility of statistical, geometric, frequency domain, and non-linear measures of 24-hour heart rate variability. Horm Metab Res (1999) 0.84
Exposure of adhesion molecules on activated platelets in patients with newly diagnosed IDDM is not normalized by near-normoglycemia. Diabetes (1995) 0.83
Correlation of islet cell antibodies and HLA-DR phenotypes with diabetes mellitus in adults. Diabetologia (1984) 0.82
Endothelin-1 inhibits the adipose differentiation of cultured human adipocyte precursor cells. Metabolism (1994) 0.82
Increased GPIIB/IIIA expression and altered DNA-ploidy pattern in megakaryocytes of diabetic BB-rats. Eur J Clin Invest (1992) 0.82
[Investigations of carbohydrate and fat metabolism in pre-diabetes]. Diabetologia (1968) 0.81
[Diagnostic and prognostic tests--requirements from biostatistical viewpoint]. Gynakologe (1983) 0.81
Functional and morphologic characterization of human insulinomas. Diabetes (1983) 0.81
Analysis of T-lymphocyte subpopulations in juvenile-onset diabetics. Clin Exp Immunol (1980) 0.81
New approach to technical and clinical evaluation of devices for self-monitoring of blood glucose. Diabetes Care (1988) 0.81
Determination of glucose turnover and glucose oxidation rates in man with stable isotope tracers. J Clin Chem Clin Biochem (1990) 0.80
Protein intake and urinary albumin excretion rates in the EURODIAB IDDM Complications Study. Diabetologia (1997) 0.80
Increased platelet volume--sign of impaired thrombopoiesis in diabetes mellitus. Klin Wochenschr (1989) 0.80
Proinsulin autoantibodies: association with type I diabetes but not with islet cell antibodies, insulin autoantibodies or HLA-DR type. J Autoimmun (1990) 0.80
[Lipoid chemical studies on angiokeratoma corporis diffusum (Fabry's syndrome)]. Klin Wochenschr (1969) 0.80
Prevalence of cardiovascular autonomic dysfunction assessed by spectral analysis and standard tests of heart-rate variation in newly diagnosed IDDM patients. Diabetes Care (1992) 0.80
[Investigations of the antilipolytic effect of insulin on human adipose tissue in vitro]. Diabetologia (1968) 0.80
The pharmacokinetics of two different concentrations of short-acting insulin, intermediate-acting insulin, and an insulin mixture following subcutaneous injection. Clin Investig (1992) 0.80
Insulinkinetic and -dynamic in diabetic patients under insulin pump therapy after injections of human insulin or the insulin analogue (B28Asp). Horm Metab Res (1995) 0.80
Increased growth stimulation of human vascular cells by serum from patients with primary hyper-LDL-cholesterolemia. Atherosclerosis (1987) 0.80
Evaluation of QT interval length, QT dispersion and myocardial m-iodobenzylguanidine uptake in insulin-dependent diabetic patients with and without autonomic neuropathy. Clin Sci (Lond) (1997) 0.80
Regulation of glycerol kinase by insulin in isolated fat cells and liver of Bar Harbor obese mice. Diabetologia (1971) 0.80
Combined subtotal pancreatectomy with selective streptozotocin infusion--a model for the induction of insulin deficiency in dogs. Res Exp Med (Berl) (1989) 0.79
Peripheral and autonomic nerve function in long-term insulin-dependent diabetes. Diabetes Res (1987) 0.79
[Influence of weight reduction on carbohydrate and fat metabolism and on serum insulin response in obesity]. Diabetologia (1968) 0.79
Natural history of glucose intolerance in obesity. A ten year observation. Int J Obes (1982) 0.79
Cytoplasmic islet cell autoantibodies: prevalence and pathognomic significance. Adv Exp Med Biol (1988) 0.79
Glycerol kinase activity in isolated fat cells of BHob mice. Horm Metab Res (1970) 0.79
In vitro studies of insulin inactivation with reference to erythroblastosis fetalis. Blood (1967) 0.79
Vascular growth factors and the development of macrovascular disease in diabetes mellitus. Diabete Metab (1987) 0.79
One-year treatment with the aldose reductase inhibitor, ponalrestat, in diabetic neuropathy. Diabetes Res Clin Pract (1991) 0.79
Long-term effects of a sustained-release preparation of acipimox on dyslipidemia and glucose metabolism in non-insulin-dependent diabetes mellitus. Metabolism (1998) 0.78
Somatic and autonomic nerve function during the first year after diagnosis of type 1 (insulin-dependent) diabetes. Diabetes Res (1988) 0.78